For active immunisation of pigs over the age of 2 weeks against porcine circovirus Type 2 (PCV2) to reduce mortality, clinical signs - including weight loss - and lesions in lymphoid tissues associated with PCV2 related diseases (PCVD). In addition, vaccination has been shown to reduced PCV2 nasal shedding, viral load in blood and lymphoid tissues, and duration of viraemia.
